Alzheimer care comparison using dementia medicines
Part of Brain & nervous system, Mental health clinical trials.
This study compares different treatment strategies for people newly diagnosed with Alzheimer disease using cholinesterase inhibitor medicines. It may help show which approach works best for mild to moderate Alzheimer symptoms and how well people can stay stable over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a new diagnosis of Alzheimer disease (not another type of dementia).
- Your Alzheimer diagnosis is “probable” or “possible,” and your memory thinking score (MMSE) is above 15.
- You are 50 years old or older, and if you can become pregnant, you are post-menopause or using effective birth control.
- You have been advised to start cholinesterase inhibitor (CI) treatment, and you have never taken these medicines before.
- You can give consent, and you have a caregiver who can participate (and you’re not in a caregiver-free situation).
- You should not have severe limits with bathing and dressing (not fully dependent).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether changing caffeine intake can improve thinking and brain function in people with Alzheimer’s disease. You may qualify if you can follow a low-caffeine diet and have stable Alzheimer’s treatment and sleep/heart conditions.
This study looks at how effective a treatment is in people newly diagnosed with mild to moderate Alzheimer’s disease. It also involves health and medication history checks and likely stool (fecal) sample collection to monitor effects.
This trial tests a new drug called CM383 in people with mild cognitive impairment or mild Alzheimer's disease. The goal is to see if it can help slow down memory loss.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
This Phase 2 trial tests a study medicine to reduce “agitation” behaviors in people with Alzheimer’s dementia. You and your caregiver would complete required assessments and may need genetic and blood testing to check how the body handles the drug.
This trial studies whether treating periodontal (gum) disease can help people who have probable Alzheimer’s disease. You may take a study treatment and have regular checks by a caregiver and study team.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.